
The only pill worth swallowing. Markets, memes, medicine, and mayhem — served straight, no chaser. Watch the video versions on YouTube : www.youtube.com/@TheShkreliPill/videos.
| Publishes | Daily | Episodes | 85 | Founded | 3 months ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | InvestingBusiness | |||

In this episode, Martin discusses developments around a potential oral PGL-1 breakthrough and what it could mean for the broader biotech landscape. He also walks through an advanced transcript on Godel, explaining how he uses it to analyze complex sc... more
In this episode, Martin discusses why he believes private equity has already positioned itself in what could become the next Nvidia. He examines what this early institutional interest may signal for the future of AI stocks and outlines how he’s think... more
Panel: Martin Shkreli, Adrian Dittmann, Outa.
Recorded on 12/23/2025.
In this episode, Martin recounts his claim that the SEC restricted his trading account and discusses how this affects his ability to manage positions moving forward. He explains why he still isn’t finished with his CAPR thesis, then shifts to broader... more
In this episode, Martin describes how a major trading setback forced him to rethink his approach and pivot professionally. He walks through what happened during the CAPR short squeeze, the market dynamics that drove it, and the lessons he drew from m... more
In this episode, Martin compares the stability of AAA bonds with the current state of the broader market, explaining how risk-adjusted returns stack up between the two. He also walks through his approach to valuing AstraZeneca’s drug pipeline, examin... more
In this episode, Martin takes a deep look at AstraZeneca, highlighting two major areas of potential he sees within the company’s long-term strategy. He breaks down AZN’s drug portfolio, reviews its key clinical programs, and explains how these compon... more
In this episode, Martin examines Google’s continued momentum, focusing on how its TPU strategy is driving renewed market optimism. He also reviews a weakening forecast for Novo Nordisk, breaking down the factors behind the shift and what it could mea... more
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #152 | |
Apple Podcasts | #244 |










Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
This podcast provides a unique blend of discussions focused on markets, investing, and the pharmaceutical industry, often with a humorous and candid tone. The hosts tackle various topics, including cutting-edge technologies like quantum computing and artificial intelligence, alongside in-depth analyses of stock performance for major companies, particularly in the biotech and pharmaceutical sectors. Noteworthy is the hosts' ability to weave personal anecdotes with financial insights, making complex subjects accessible and entertaining for an audience interested in investment strategies and industry trends.
Listeners are likely to find the program appealing due to its emphasis on real-world investment experiences paired with critical comment... more
Rephonic provides a wide range of podcast stats for The Shkreli Pill. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Shkreli Pill and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for The Shkreli Pill, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for The Shkreli Pill, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers The Shkreli Pill has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
The Shkreli Pill launched 3 months ago and published 85 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for The Shkreli Pill from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of The Shkreli Pill. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.